Table of Contents
<< Previous Issue | Mar 2007 (Vol: 2007, Issue: 81) | Next Issue >> |
- Section: Business Commentaries
-
What's a good pipeline?
- Section: Cartoons
-
Nearly
- Section: Deal Trackers
-
Advexin (adenoviral p53)
- Section: Features
-
Flexibility and Fortune: AstraZeneca’s Strategic Shift
-
H5N1: Preparing for the Worst
-
The Pharmaceutical Deals of 2006: Lessons for 2007
-
Viral Gene Delivery #8211; Gene Therapy and Beyond
- Section: General
-
Synergy or Vanity: the Appetite for Pharma Mega-Mergers
-
Amsterdam Molecular Therapeutics (AMT B.V.)
- Section: Licensing
-
GSK and XenoPort to Collaborate on Late-Stage Compound for RLS and Neuropathic Pain
-
Elbion in Deals for Neurological Products
- Section: Mergers & Acquisitions
-
Cardinal Divests Segment to Blackstone
-
Hikma Set to Enter Oncology Market with Acquisition of ribosepharm
- Section: Research & Development
-
VASTox Signs Drug Discovery Deals Worth a Combined US$1.3 M